Volume 32, Number 6—June 2026
Synopsis
Outcomes of Hospitalized and Critically Ill Adults with Murine Typhus, Galveston, Texas, USA, 2019–2023
Table 1
Characteristics of hospitalized patients in study of outcomes of hospitalized and critically ill adults with murine typhus, Galveston, Texas, USA, 2019–2023*
| Characteristic | All hospitalized patients, n = 119 | Non-ICU, n = 86 | ICU, n = 33 | p value |
|---|---|---|---|---|
| Mean age, y (SD) |
49.3 (16.6) |
47.2 (16.4) |
54.9 (15.9) |
0.022 |
| Sex | 0.074 | |||
| M | 60 (50.4) | 39 (45.35) | 21 (63.6) | |
| F |
59 (49.6) |
47 (54.65) |
12 (36.4) |
|
| Race | ||||
| White | 115 (96.6) | 82 (95.35) | 33 (100) | 0.208 |
| Non-white |
4 (3.4) |
4 (4.65) |
0 (0) |
|
| Ethnicity | 0.258 | |||
| Hispanic | 43 (36.1) | 32 (37.2) | 11 (33.3) | |
| Not Hispanic | 75 (63.1) | 54 (62.8) | 21 (63.6) | |
| Unknown |
1 (0.8) |
0 (0) |
1 (3) |
|
| Mean Charlson Comorbidity Index (SD) |
1.05 (1.4) |
0.98 (1.4) |
1.24 (1.4) |
0.247 |
| Comorbidities | ||||
| Alcohol abuse | 6 (5.0) | 4 (4.7) | 4 (12.1) | 0.145 |
| Renal disease | 10 (8.4) | 7 (8.1) | 3 (9.1) | 0.867 |
| Diabetes | 19 (16.0) | 14 (16.3) | 5 (15.1) | 0.881 |
| Cerebrovascular disease | 7 (5.9) | 4 (4.6) | 3 (9.1) | 0.357 |
| Obesity |
33 (27.7) |
23 (26.7) |
10 (30.3) |
0.698 |
| Most common diagnoses at time of admission (%) | ||||
| Typhus (17.5); fever (39.5) | Fever (15.2); sepsis (33.3) | |||
| Sepsis (8); typhus (17.5) | Acute kidney failure (3); fever (15.2) | |||
| Pneumonia (4.7); sepsis (8) | Acute respiratory failure with hypoxia (3); acute kidney failure (3) | |||
| Altered mental status (2.3); pneumonia (4.7) | Dehydration (3); acute respiratory failure with hypoxia (3) | |||
| Altered mental status (2.3) | Dehydration (3) | |||
*Values are no. (%) except as indicated. ICU, intensive care unit.
Page created: April 29, 2026
Page updated: June 01, 2026
Page reviewed: June 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.